why do some people not lose weight on glp 1 The Other Side of GLP-1 Why Some People Don't Lose

Learn about GLP-1 drug interactions & nutrient deficiencies with Ozempic, Wegovy & Mounjaro

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

Novel therapies, including melatonin supplementation and modulation of the gut microbiome, are explored

Learn why some patients experience cramping on semaglutide or tirzepatide, the indirect mechanisms involved, and evidence-based strategies to prevent and manage muscle symptoms during GLP-1 therapy.

The FDA criticized the maker of Ozempic and Wegovy, Novo Nordisk, for serious violations related to the reporting of possible side effects linked to semaglutide, the active ingredient in the drug

Tirzepatide prescriptions are available online for weight loss at Klinic